Davis, United States
ARIZ Precision Medicine, founded in 2015 and based in Davis, California, is making waves in the Biotechnology, Healthcare, and Pharmaceutical industries. The company's mission is captured by its compelling slogan: "Targeting Cancer at the Root Cause." ARIZ is a pre-clinical stage company that is pioneering innovations outside the realm of traditional oncology treatments.
By targeting the deregulated PRDM genes and proteins, traditionally considered "undruggable," ARIZ aims to selectively destroy cancer cells while sparing normal cells. This is achieved using proprietary siRNA constructs and advanced drug delivery nanotechnologies. Initial proof of principle studies have shown promising results across multiple cancer types, including breast, colon, and lung cancers.
The company recently secured a $1.00M Convertible Note investment from Moneta Ventures as of March 16, 2022, which underscores investor confidence in ARIZ's innovative approach. ARIZ is positioning itself to enter strategic partnerships with pharmaceutical companies, paving the way for clinical testing and market introduction, ultimately striving to cure cancers while preserving patient quality of life.
